Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026)
Omeros (OMER) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Omeros | 1.24 Bn | 1.24 Bn | 27.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15,850.00 |
| Mar 31, 2026 | 3,895.00 |
| Jun 30, 2022 | -30,099.00 |
| Mar 31, 2022 | -39,713.00 |
| Dec 31, 2021 | 14,557.00 |
| Sep 30, 2021 | -2,611.00 |
| Jun 30, 2021 | -4,900.00 |
| Mar 31, 2021 | 4,715.00 |
| Dec 31, 2020 | -4,780.00 |
| Sep 30, 2020 | 49,486.00 |
| Jun 30, 2020 | 29,642.00 |
| Mar 31, 2020 | 452,054.00 |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 796,843.00 |
| Jun 30, 2019 | 3.82 Mn |
| Mar 31, 2019 | 1.56 Mn |
| Dec 31, 2018 | 814,213.00 |
| Sep 30, 2018 | 608,494.00 |
| Jun 30, 2018 | 755,003.00 |
| Mar 31, 2018 | -82,857.00 |